101 related articles for article (PubMed ID: 28889092)
1. Quantitative MR spectroscopic imaging in metachromatic leukodystrophy: value for prognosis and treatment.
van Rappard DF; Klauser A; Steenweg ME; Boelens JJ; Bugiani M; van der Knaap MS; Wolf NI; Pouwels PJW
J Neurol Neurosurg Psychiatry; 2018 Jan; 89(1):105-111. PubMed ID: 28889092
[TBL] [Abstract][Full Text] [Related]
2. MR-spectroscopy in metachromatic leukodystrophy: A model free approach and clinical correlation.
Feldmann J; Martin P; Bender B; Laugwitz L; Zizmare L; Trautwein C; Krägeloh-Mann I; Klose U; Groeschel S
Neuroimage Clin; 2023; 37():103296. PubMed ID: 36563646
[TBL] [Abstract][Full Text] [Related]
3. Alterations of brain metabolites in metachromatic leukodystrophy as detected by localized proton magnetic resonance spectroscopy in vivo.
Kruse B; Hanefeld F; Christen HJ; Bruhn H; Michaelis T; Hänicke W; Frahm J
J Neurol; 1993 Dec; 241(2):68-74. PubMed ID: 7908027
[TBL] [Abstract][Full Text] [Related]
4. Brain N-acetylaspartate levels correlate with motor function in metachromatic leukodystrophy.
i Dali C; Hanson LG; Barton NW; Fogh J; Nair N; Lund AM
Neurology; 2010 Nov; 75(21):1896-903. PubMed ID: 21098404
[TBL] [Abstract][Full Text] [Related]
5. Diffusion tensor imaging in metachromatic leukodystrophy.
van Rappard DF; Königs M; Steenweg ME; Boelens JJ; Oosterlaan J; van der Knaap MS; Wolf NI; Pouwels PJW
J Neurol; 2018 Mar; 265(3):659-668. PubMed ID: 29383515
[TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance spectroscopy predicts outcomes for children with nonaccidental trauma.
Aaen GS; Holshouser BA; Sheridan C; Colbert C; McKenney M; Kido D; Ashwal S
Pediatrics; 2010 Feb; 125(2):295-303. PubMed ID: 20123781
[TBL] [Abstract][Full Text] [Related]
7. Metabolic alterations in medication-free patients with bipolar disorder: a 3T CSF-corrected magnetic resonance spectroscopic imaging study.
Port JD; Unal SS; Mrazek DA; Marcus SM
Psychiatry Res; 2008 Feb; 162(2):113-21. PubMed ID: 18164911
[TBL] [Abstract][Full Text] [Related]
8. Alterations in frontal white matter neurochemistry and microstructure in schizophrenia: implications for neuroinflammation.
Chiappelli J; Hong LE; Wijtenburg SA; Du X; Gaston F; Kochunov P; Rowland LM
Transl Psychiatry; 2015 Apr; 5(4):e548. PubMed ID: 25871973
[TBL] [Abstract][Full Text] [Related]
9. Quantitative in vivo brain magnetic resonance spectroscopic monitoring of neurological involvement in mucopolysaccharidosis type II (Hunter Syndrome).
Davison JE; Hendriksz CJ; Sun Y; Davies NP; Gissen P; Peet AC
J Inherit Metab Dis; 2010 Dec; 33 Suppl 3():S395-9. PubMed ID: 20886296
[TBL] [Abstract][Full Text] [Related]
10. Proton MRS in acute traumatic brain injury: role for glutamate/glutamine and choline for outcome prediction.
Shutter L; Tong KA; Holshouser BA
J Neurotrauma; 2004 Dec; 21(12):1693-705. PubMed ID: 15684761
[TBL] [Abstract][Full Text] [Related]
11. A combined diffusion tensor imaging and magnetic resonance spectroscopy study of patients with schizophrenia.
Reid MA; White DM; Kraguljac NV; Lahti AC
Schizophr Res; 2016 Feb; 170(2-3):341-50. PubMed ID: 26718333
[TBL] [Abstract][Full Text] [Related]
12. Regional age dependence of human brain metabolites from infancy to adulthood as detected by quantitative localized proton MRS.
Pouwels PJ; Brockmann K; Kruse B; Wilken B; Wick M; Hanefeld F; Frahm J
Pediatr Res; 1999 Oct; 46(4):474-85. PubMed ID: 10509371
[TBL] [Abstract][Full Text] [Related]
13. Altered white matter metabolism in delayed neurologic sequelae after carbon monoxide poisoning: A proton magnetic resonance spectroscopic study.
Kuroda H; Fujihara K; Mugikura S; Takahashi S; Kushimoto S; Aoki M
J Neurol Sci; 2016 Jan; 360():161-9. PubMed ID: 26723994
[TBL] [Abstract][Full Text] [Related]
14. High-resolution magic angle spinning and 1H magnetic resonance spectroscopy reveal significantly altered neuronal metabolite profiles in CLN1 but not in CLN3.
Sitter B; Autti T; Tyynelä J; Sonnewald U; Bathen TF; Puranen J; Santavuori P; Haltia MJ; Paetau A; Polvikoski T; Gribbestad IS; Häkkinen AM
J Neurosci Res; 2004 Sep; 77(5):762-9. PubMed ID: 15352223
[TBL] [Abstract][Full Text] [Related]
15. Proton MR spectroscopy after acute central nervous system injury: outcome prediction in neonates, infants, and children.
Holshouser BA; Ashwal S; Luh GY; Shu S; Kahlon S; Auld KL; Tomasi LG; Perkin RM; Hinshaw DB
Radiology; 1997 Feb; 202(2):487-96. PubMed ID: 9015079
[TBL] [Abstract][Full Text] [Related]
16. Quantitative multivoxel proton spectroscopy of the brain in developmental delay.
Verbruggen KT; Maurits NM; Meiners LC; Brouwer OF; van Spronsen FJ; Sijens PE
J Magn Reson Imaging; 2009 Oct; 30(4):716-21. PubMed ID: 19787717
[TBL] [Abstract][Full Text] [Related]
17. Axonal injury and membrane alterations in Alzheimer's disease suggested by in vivo proton magnetic resonance spectroscopic imaging.
Meyerhoff DJ; MacKay S; Constans JM; Norman D; Van Dyke C; Fein G; Weiner MW
Ann Neurol; 1994 Jul; 36(1):40-7. PubMed ID: 8024260
[TBL] [Abstract][Full Text] [Related]
18. Case control study: magnetic resonance spectroscopy of brain in HIV infected patients.
Bairwa D; Kumar V; Vyas S; Das BK; Srivastava AK; Pandey RM; Sharma SK; Jagannathan NR; Sinha S
BMC Neurol; 2016 Jul; 16():99. PubMed ID: 27405321
[TBL] [Abstract][Full Text] [Related]
19. Prediction of functional outcome 18 months after a first psychotic episode: a proton magnetic resonance spectroscopy study.
Wood SJ; Berger GE; Lambert M; Conus P; Velakoulis D; Stuart GW; Desmond P; McGorry PD; Pantelis C
Arch Gen Psychiatry; 2006 Sep; 63(9):969-76. PubMed ID: 16952999
[TBL] [Abstract][Full Text] [Related]
20. Cerebral diffusion tensor imaging and in vivo proton magnetic resonance spectroscopy in patients with fulminant hepatic failure.
Saksena S; Rai V; Saraswat VA; Rathore RS; Purwar A; Kumar M; Thomas MA; Gupta RK
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e111-9. PubMed ID: 17924951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
